Purchase Order 36C25525P0023

Award Date 10/21/24
Potential Completion Date 12/31/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,660.80, is for the delivery of three vascular stents to be used in the VA's healthcare facilities. The contract has an ultimate completion date of March 31, 2025 and was awarded on December 3, 2024. Bard is a for-profit medical device manufacturer that has a long-standing...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard. The contract, valued at $14,946.13, is for the delivery of three (3) vascular stents to support the VA's medical device needs. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology manufacturer, and has been providing a range of medical devices and supplies to the...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 15 (VISN 15), to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of two vascular stents, with a ceiling value of $10,162.79 and a period of performance ending on March 31, 2025. The contract does not have a set-aside designation, indicating that Bard competed for the...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company. The contract is for the delivery of three vascular stents, with a total ceiling value of $15,000.00 and a period of performance ending on March 31, 2025. Bard is a for-profit organization and a manufacturer of various medical devices and supplies, including vascular stents,...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,891.00, is for the delivery of three (3) vascular stents to support the VA's healthcare operations. The contract has an ultimate completion date of December 31, 2024 and does not utilize any set-aside designations. Bard is a manufacturer of a wide range of medical devices and...
This is a firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc. (operating as Bard), a subsidiary of Becton, Dickinson and Company (BD). The $25,405.60 contract is for the supply of vascular stents to support healthcare delivery across the VA's integrated service networks. Bard, a major medical device manufacturer, has a long history of federal contract awards from the VA, Department of Defense (DoD), and other agencies for a range of products...
The U.S. Department of Veterans Affairs (VA), specifically through Veterans Integrated Service Network (VISN) 15, awarded a firm-fixed-price purchase order to C.R. Bard, Inc., doing business as Bard, for the delivery of three vascular stents. The contract has a ceiling value of $14,769.26 and an ultimate completion date of June 30, 2025. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology manufacturer, and is registered as a for-profit organization in SAM.gov....
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the U.S. Department of Veterans Affairs (VA), to C.R. Bard, Inc. (Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the provision of vascular stents, with a ceiling value of $12,702.80 and a performance period ending on December 31, 2024. Bard is an established medical device manufacturer that has received numerous federal contracts from the VA...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The $11,001.00 contract is for the delivery of STENTS and has an ultimate completion date of October 16, 2024. Bard is a manufacturer of medical devices, including vascular stents, surgical implants, catheters, and other specialized equipment used in healthcare settings. The contract was awarded through the...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 15 (VISN 15), to C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of two vascular stents, with a ceiling value of $10,162.79 and a period of performance ending on June 30, 2025. The contract is not set aside for any specific business type. C.R. Bard, Inc. is a for-profit manufacturer of...

This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the Department of Veterans Affairs (VA), to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of vascular stents (x3) for $22,992.20, with a completion date of December 31, 2024. Bard is a for-profit organization and manufacturer of medical devices that has received numerous federal contract awards from the VA and Department of Defense (DoD) for a variety of products, including specialized medical equipment, surgical implants, and catheters. This contract award is not associated with any set-aside designation, indicating that Bard competed for the award based on its capabilities and product offerings.

Generated 10/22/24, 9:03 AM